成熟期光强对烤烟理化特性和致香成分含量的影响

2004、2005年在四川凉山烟科所通过盆栽试验,在烤烟成熟期营造不同的光照强度,研究了成熟期光强不同对烤烟品质的影响。结果表明:成熟期随着光照强度的降低,叶片厚度降低,栅栏组织/海绵组织的比值降低,烤后烟叶单叶重、厚度、叶质重降低,叶片含梗率增加,总糖和还原糖含量降低,总氮和烟碱含量升高,钾和氯含量增加,叶黄素、β-胡萝卜素和类胡萝卜素总量增加,中性致香成分含量呈增加趋势,增加到一定程度开始降低。     

光照强度对烤烟光合特性及其生长和品质的影响

以NC89烟草品种为材料,用白纱布遮荫研究了100%、80%、50%和20%全光照处理对烤烟生长发育、光合特性及化学成分的影响.结果表明:(1)随光照强度的减弱,植株茎杆变细,叶片的长宽比增加,叶片数减少,出叶速度变慢,干物质重逐渐减少,并以80%的全光照条件下的株高、叶面积最大.(2)净光合速率(Pn)、气孔导度(Gs)、蒸腾速率(Tr)、叶绿素a/b值均随光照减弱而逐渐下降,胞间CO2浓度(Ci)、叶绿素含量逐渐升高;叶绿素荧光参数Fm、ФPSⅡ、Fv/Fm、QP值逐渐增加.(3)烟碱、淀粉、还原糖、水溶性总糖、总酚含量随光照减弱而降低,而总氮和钾含量升高.综合分析各项测定指标发现,在大于或等于80%全光照(光照强度为770~1 125μmol?m-2?s-1)条件下,烤烟的生长指标变化不大,品质指标符合不同卷烟工业需要,适合优质烟叶的生产.     

土壤施硒对烤烟生理指标的影响

以烤烟品种K326盆栽试验为基础,研究了不同浓度Se对烤烟生长过程中生理特性、烤烟叶片硒含量及硒积累速率的影响.结果表明:低浓度Se(≤8 mg/kg)对烤烟叶片中叶绿素a、叶绿素b、叶绿素a+b和类胡萝卜素含量有促进作用,可提高烤烟叶片中SOD、POD活性;高浓度硒(≥12mg/kg)降低了烤烟叶片SOD、POD活性,烟株生长受到抑制甚至死亡.在适宜的硒浓度范围内,烤烟MDA含量有所降低,缓解了膜脂的过氧化程度;POD活性随着生育期的延长而提高;烤烟生长前期的SOD活性高于后期;烤烟生长中期的MDA含量明显低于前期和后期.随着土壤中硒含量的增加,烤烟叶片中的硒含量逐渐递增,而硒在烤烟叶片中的积累速率呈现出先增高后降低的趋势.     

遮荫对半夏叶片光合色素与保护酶活性的影响

对半夏进行不同程度遮荫处理,研究了其生长过程中叶组织的光合色素含量、叶绿素a/b值、保护酶体系(SOD、POD、CAT)活性和丙二醛(MDA)含量的变化及其生理特性.结果表明:不同处理的半夏在生长过程中,光合色素的含量呈先升后降的趋势;与全光照相比,遮荫处理的叶绿素含量较高,叶绿素a/b值较低,类胡萝卜素含量在生长发育中早期较低而后期较高;SOD、POD、CAT活性呈由低到高再降低的趋势,MDA含量持续升高;遮荫处理的SOD、POD活性和MDA含量均低于全光照处理,CAT活性则表现为先高于后低于全光照处理.适度的遮荫可以提高半夏叶绿素的含量,降低膜系统受到的伤害,改善半夏的倒苗状况,为半夏叶片的生长提供较好的环境.     

不同遮荫度对‘红叶’南天竹叶色变化及矿质营养积累的影响

为探讨遮荫对‘红叶’南天竹(Nandina domestica‘Hongye’)叶色及矿质营养积累的影响,对不同遮荫处理下其生理生化指标的变化进行了研究。结果表明,随遮荫度增加,叶绿素、类胡萝卜素含量增加,花色素苷相对含量减少,可溶性糖含量差异不明显。随处理时间的延长,不同遮荫度的花色素苷相对含量都明显增加,可溶性糖含量与花色素苷后期变化相似,叶绿素和类胡萝卜素含量在全光照(CK)及30%遮荫度(C1)有所增加,55%遮荫度(C2)下变化比较平稳,而75%遮荫度(C3)呈先减少后增加的变化趋势。叶片中氮含量在较大遮荫度时较高,磷、钾含量在中度遮荫时较高,钙含量随遮荫度的增高而减少,镁和铁在不同遮荫度间差异不显著。相关性分析表明,花色素苷含量与可溶性糖、钙含量呈显著正相关(P0.05),与氮含量呈显著负相关(P0.05);而叶绿素含量与氮含量呈显著正相关(P0.05),与钾、钙含量呈显著负相关(P0.05)。因此,遮荫可以影响‘红叶’南天竹叶片色素、可溶性糖及矿质元素的含量,适宜摆放或种植在30%遮荫度的疏荫环境中,不仅生长表现良好,而且呈色最佳。     

遮荫对紫叶李幼苗叶片色素含量及光合速率的影响

以露地栽培的1年生紫叶李和绿叶李为试材,研究了全光照(CK)、中度遮荫(透光率为43%)、重度遮荫(透光率为27%)处理下叶片色素含量及净光合速率的变化.结果表明:在夏季,各处理紫叶李幼苗叶片叶绿素含量、类胡萝卜素含量随遮荫时间的延长逐渐升高,花色素苷含量、花色素苷含量/叶绿素含量比值降低;在秋季,各处理紫叶李幼苗叶片叶绿素含量、类胡萝卜素含量先升高后降低,而花色素苷含量、花色素苷含量/叶绿素含量比值则先降低后升高.在夏秋两季,紫叶李3种色素含量均高于绿叶李,全光照下的紫叶李叶片花色素苷含量、花色素苷含量/叶绿素含量比值及净光合速率日积分值均高于遮荫处理.紫叶李具备一定的喜光性,全光照环境有利于其彩色的呈现和光合性能的发挥.     

不同生育期花生渗透调节物质含量和抗氧化酶活性对土壤水分的响应

通过防雨棚池栽试验,以不同花生品种为试材,研究了不同生育时期非充分灌溉对花生品种各生育期叶片膜脂过氧化、渗透调节物质含量和抗氧化酶活性的影响.结果表明,苗期和花针期灌水,叶片抗氧化酶活性、渗透调节物质和丙二醛(MDA)含量均有不同程度的降低.随生育期推进和土壤水分降低,其活性升高,但升幅因品种、抗氧化酶和渗透调节物质类型有异,两品种叶片超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、可溶性糖(SS)、可溶性蛋白质(Pr)、游离氨基酸(AA)和脯氨酸(Pro)含量均以对水分最为敏感的花针期升幅较大,且花育27号的SOD、CAT、Pr和AA的升幅大于花育20号;结荚期灌水后,各抗氧化酶和渗透调节物质未表现降低.两品种全生育期灌水处理与苗期灌水处理间的抗氧化酶活性、渗透调节物质和MDA含量差异均不显著.水分胁迫初期,抗氧化酶活性升高,但随胁迫时间延长其活性明显降低;而渗透调节物质和MDA含量显著高于各生育期灌水处理.POD活性变化对灌水处理响应较弱,SOD和CAT是花生适应土壤水逆境的主要保护酶.灌水处理对花生叶片抗氧化及渗透调节能力表现为花针期＞结荚期＞苗期,各渗透物质调节能力依次表现为脯氨酸、可溶性蛋白质＞可溶性糖＞游离氨基酸.     

遮荫对青桐幼苗生长性状与化学计量特征的影响

营养元素含量及化学计量比可反映植物器官营养元素的分配及互作关系,亦可反映其营养利用效率及生长环境的养分限制状况。以青桐(Firmiana platanifolia)幼苗为材料,分析4种不同光强(全光照,50%、75%和95%遮荫)对青桐幼苗生长,C、N、P、K含量及其化学计量特征的影响。结果表明:遮荫对青桐幼苗的生长性状、生物量、元素含量和积累量及化学计量比均有显著影响(P<0.05)。苗高和比叶面积随遮荫强度增加而升高,而地径和粗壮度随遮荫强度增加而减小。总生物量在75%遮荫下最大,在95%遮荫下最小。在各遮荫处理下,叶片C、N、P、K含量均大于根和茎,且N含量顺序为叶>根>茎,K含量顺序为叶>茎>根。C、P、K积累量随遮荫强度增大而增加,在75%遮荫下达到最大值,而在95%遮荫下达到最小值。青桐幼苗C∶N和C∶P呈现出相同的变化趋势,随遮荫强度变大先增加后减小,均在50%遮荫下达最大值。青桐各器官N∶P远低于14,即青桐幼苗在不同遮荫条件下的生长严重受N限制。这些结果说明,遮荫可调节青桐幼苗在不同光环境中的养分积累与分配,进而影响生物量。因此,青桐苗期培育宜选75%遮荫,有助于苗高、比叶面积、生物量、养分含量和积累量的增加,而过度遮荫可抑制幼苗生长发育。     

遮荫处理对罗汉果果肉组织中罗汉果苷和糖分含量的影响

该研究以罗汉果品种“永青1号”为材料,在果实发育后期进行不同强度的遮荫处理,测定遮荫处理下果肉组织中罗汉果苷各组分含量、各种糖分的积累及其相关糖代谢酶活性、叶片光合特性的变化。结果表明：重度遮荫(70％遮荫)会导致果实中罗汉果甜苷Ⅴ含量显著提高,遮荫60 d(授粉后90 d),对照与70％遮荫处理果实中罗汉果甜苷Ⅴ含量分别为4.83％、5.79％,差异达极显著水平( P<0.01);70％遮荫处理下果实中葡萄糖、果糖含量也明显高于对照( P<0.05)。与罗汉果甜苷Ⅴ、葡萄糖、果糖含量的变化不同,遮荫60 d,70％遮荫处理下罗汉果果实中可溶性糖、蔗糖的含量分别显著(P<0.05)和极显著(P<0.01)低于对照。另外,遮荫处理导致罗汉果叶片净光合速率下降,遮荫40 d,70％遮荫处理下叶片的净光合速率显著低于对照( P<0.05)。综上说明,重度遮荫处理可以引起罗汉果果实品质的改变;光合速率下降是遮荫处理下可溶性糖含量降低的主要原因;SPS、AI、SSC活性的改变则是遮荫导致蔗糖含量降低及葡萄糖、果糖含量上升的重要因素;重度遮荫条件下,荫棚中温度降低可能是罗汉果果实中甜苷Ⅴ含量增高的关键诱因。该研究结果为罗汉果的生产及品质调控提供了理论依据。     

杨树幼苗非结构性碳水化合物对增加降水和氮添加的响应

设置3个水分梯度,即自然降水(W₁)、自然降水增加50%(W₂)和增加100%(W₃)以及4个施氮梯度,即模拟氮沉降添加0(N₁)、5(N₂)、10(N₃)和15(N₄) g N·m^-2·a^-1,研究增加降水和氮添加对杨树幼苗非结构性碳水化合物(NSC)的影响.结果表明: 增加降水和氮添加对杨树幼苗NSC含量具有显著的交互作用.随着降水的增加,N₁水平叶片和枝条可溶性糖含量不变,叶片、枝条、主干、粗根和细根淀粉含量下降;N₂和N₃水平各器官可溶性糖含量下降或保持不变,淀粉含量降低或先升高后降低;N₄水平各器官可溶性糖和淀粉含量升高或先降低后升高.随着氮沉降的增加,W₁处理叶片可溶性糖含量不变,淀粉含量增加,细根可溶性糖含量增加,淀粉含量不变;W₂处理各器官可溶性糖含量不变或先增加后减少,淀粉含量降低或先增加后降低;W₃处理各器官可溶性糖、淀粉和NSC含量均增加.各水分和施氮梯度处理下,杨树幼苗可溶性糖含量为39.1～88.3 mg·g^-1,叶片中最高,细根中最低,淀粉含量为23.3～46.8 mg·g^-1,粗根中最高,细根中最低.     

The growth of growth

Over a 40-year period, 1940 through the present, human growth research has increased from a minimal to a major part of physical anthropology. Such research, originally conducted at the major American growth centers, has become more diverse and more specialized, extending to National Probability Samplings, nutritional surveys, studies of twins, investigations restricted to the craniofacial complex, and studies of the growth and development of various primate species. Besides extending knowledge of growth and development in general and control mechanisms in particular, there has been major feedback into physical anthropology affording far greater understanding of human variability, of taxonomic differences, and of changes previously believed to be phylogenetic in nature. To the larger extent, all physical anthropologists have some degree of growth awareness.     

Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth

To examine the relationship between growth hormone (GH) and insulin-like growth factor 1 (IGF1) in controlling postnatal growth, we performed a comparative analysis of dwarfing phenotypes manifested in mouse mutants lacking GH receptor, IGF1, or both. This genetic study has provided conclusive evidence demonstrating that GH and IGF1 promote postnatal growth by both independent and common functions, as the growth retardation of double Ghr/Igf1 nullizygotes is more severe than that observed with either class of single mutant. In fact, the body weight of these double-mutant mice is only approximately 17% of normal and, in absolute magnitude ( approximately 5 g), only twice that of the smallest known mammal. Thus, the growth control pathway in which the components of the GH/IGF1 signaling systems participate constitutes the major determinant of body size. To complement this conclusion mainly based on extensive growth curve analyses, we also present details concerning the involvement of the GH/IGF1 axis in linear growth derived by a developmental study of long bone ossification in the mutants.     

Insulin-like growth factor inhibition of growth hormone secretion

Somatomedins-insulin-like growth factors (SM/IGF) are growth hormone (GH) dependent serum growth factors. There is some evidence that IGF inhibit GH release (negative feedback) in 3- to 24-h incubations of cultured rat adenohypophysial cells. We have used acutely dispersed noncultured rat adenohypophysial cells to study the dynamics of IGF on GH secretion. In this system both IGF-I and IGF-II (100 ng/mL) slightly, but significantly, decrease the cumulative GH released by human pancreas growth hormone releasing factor 1-40 (GRF) and the phosphodiesterase inhibitor 3-isobutyl-1-methyl xanthine. The inhibition is small (16%) and usually not statistically significant until 2 h of incubation. The inhibition with IGF is additive to that produced with low concentrations of somatostatin. The IGF also significantly decrease the rate of GH release in all time periods tested (0-1, 1-2, 2-3 h). In addition, the IGF decrease the quantity of [14C]leucine protein eluted at the position of labelled rat GH on Sephadex G75, which would include newly synthesized GH extracted from the cells. Thus we conclude that the decreased GH released may be due to an effect of IGF on both rate of release and on GH synthesis.     

Dosing of growth hormone in growth hormone deficiency

Growth hormone (GH) treatment of GH-deficient (GHD) children is to a certain extent standardized worldwide. Recombinant 22 kDa GH is injected once daily by the subcutaneous route, mostly in the evening. The amount of GH injected (calculated per kg body weight or body surface area, expressed in terms of IU or mg) in prepubertal children mimics the known production rate (approximately 0.02 mg [0. 06 IU]/kg body weight per day). However, there is a wide variation in dosage, the reasons for which are partly unknown and partly due to national traditions and regimes imposed by authorities regulating reimbursement. The situation during puberty is less standardized, with most clinicians still not increasing the dosage according to known production rates. The results of these approaches in terms of adult height outcome are not always satisfactory. In order to achieve optimal height development during childhood, puberty and adulthood, strategies must be developed to individualize GH dosing according to set therapeutical goals taking into account efficacy, safety and cost. The implementation of prediction algorithms will help us to reach these goals. In addition, other response variables will have to be monitored during treatment in order to correct for deficits resulting from GHD.     

Platelet-derived growth factor or basic fibroblast growth factor induce anchorage-independent growth of human fibroblasts

Anchorage-independent growth, i.e., growth in semi-solid medium is considered a marker of cellular transformation of fibroblast cells. Diploid human fibroblasts ordinarily do not exhibit such growth but can grow transiently when medium contains high concentrations of fetal bovine serum. This suggests that some growth factor(s) in serum is responsible for anchorage-independent growth. Much work has been done to characterize the peptide growth factor requirements of various rodent fibroblast cells for anchorage-independent growth; however, the requirements of human fibroblasts are not known. To determine the peptide growth factor requirements of human fibroblasts for anchorage-independent growth, we used medium containing serum that had had its peptide growth factors inactivated. We found that either platelet-derived growth factor (PDGF) or the basic form of fibroblast growth factor (bFGF) induced anchorage-independent growth. Epidermal growth factor (EGF) did not enhance the growth induced by PDGF, or did so only slightly. Transforming growth factor beta (TGF-beta) decreased the growth induced by PDGF. EGF combined with TGF-beta induced colony formation in semi-solid medium at concentrations at which neither growth factor by itself was effective, but the combination was much less effective in stimulating anchorage-independent growth than PDGF or bFGF. This work showed that PDGF, or bFGF, or EGF combined with TGF-beta can stimulate anchorage-independent growth of nontransformed human fibroblasts. The results support the idea that cellular transformation may reduce or eliminate the need for exogenous PDGF or bFGF.     

Molar growth yield of Nitrobacter winogradskyi during exponential growth

A numerical analysis of experimental growth curves obtained for Nitrobacter by observing changes in cell numbers, substrate concentration and rate of heat evolution has allowed the calculation of the growth rate constants during the phase of balanced growth. The molar growth yield was smaller during that phase than during the phase preceding it. On the other hand, the rate of heat evolution was larger during exponential growth by a factor of about 1.5 than during the stages up to and including this phase. The two observations being in agreement since, if less efficient synthesis occurs during exponential growth, more free energy must be dissipated as heat.     

Transforming growth factors and control of neoplastic cell growth

Transforming growth factors (TGFs) are peptides that affect the growth and phenotype of cultured cells and bring about in nonmalignant fibroblastic cells phenotypic properties that resemble those of malignant cells. Two types of TGFs have been well characterized. One of these, TGF alpha, is related to epidermal growth factor (EGF) and binds to the EGF receptor, whereas the other, TGF beta, is not structurally or functionally related to TGF alpha or EGF and mediates its effects via distinct receptors. TGF beta is produced by a variety of normal and malignant cells. Depending upon the assay system employed, TGF beta has both growth-inhibitory and growth-stimulating properties. Many of the mitogenic effects of TGF beta are probably an indirect result of the activation of certain growth factor genes in the target cell. The ubiquitous nature of the TGF beta receptor and the production of TGF beta in a latent form by most cultured cells suggests that the differing cellular responses to TGF beta are regulated either by events involved in the activation of the factor or by postreceptor mechanisms. The combined effects of TGF beta with other growth factors or inhibitors evidently play a central role in the control of normal and malignant cellular growth as well as in cell differentiation and morphogenesis. Since transforming growth factor as a concept has partially proven misleading and insufficient, there is a need to find a new nomenclature for these regulators of cellular growth and differentiation.     

Retardation of tree growth by injection of plant growth regulators

Previously topped American sycamore (Platanus occidentalis L.), cottonwood (Populus deltoides Bartr. ex Marsh), water oak (Quercus nigra L.), and bigleaf maple (Acer macrophyllum Pursh) trees were injected with aqueous solutions of maleic hydrazide or dikegulac-sodium in April-June, 1979 at various locations around the United States. Measurements made later in the autumn showed that dikegulac-sodium reduced sprout regrowth in all four species, whereas maleic hydrazide was only effective in controlling regrowth of American sycamore and cottonwood. The effects of dikegulac persisted through the second growing season. Significant variability was observed among treated trees and must be reduced in order to achieve consistent growth responses from an application of growth retardants.This paper reports the results of research only. Mention of a growth regulator does not consitute a recommendation for use by the U.S. Department of Agriculture nor does it imply registration under FIFRA as amended. Mention of a trademark or propriety product does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable.